Clinical Trial Update: Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide in combination with ICE for refractory/relapsed diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• ICE
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B-Cell Lymphoma Refractory | Phase 2 | Status: UNKNOWN